Data Foundry

Medical device recalls 2016

Neural Signal Amplifier — Class II medical device recall Z-2763-2016

Terminated recall by Blackrock Microsystems, LLC, reported 2016-09-14, distributed nationwide. Blackrock Microsystems, LLC announces a voluntary field action for the Blackrock NeuroPort Biopotential Signal

Recall numberZ-2763-2016
Product typeMedical device
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmBlackrock Microsystems, LLC, Salt Lake City, UT, United States
Recall initiated2016-08-10
Classified2016-09-08
Reported by FDA2016-09-14
Terminated2017-08-21
DistributedNationwide (US)
Countries outside the USCA
Quantity81 amplifiers
Reason classeslabeling
Serial numbers0014, 0016
Model numbers4208, 5703, 5747, 5748, 5749

Product

Neural Signal Amplifier. Part Numbers: 4208, 5703, 5749, 5748, 5747. Product Usage: The Blackrock NeuroPort Biopotential Signal Processing System supports recording, processing and display of biopotential signals from user supplied electrodes. Biopotential signals include: Electrocorticography (ECoG), electroencephalography (EEG), electromyography (EMG), electrocardiography (ECG), electrooculography (EOG) and Evoked Potential (EP)

Reason for recall

Blackrock Microsystems, LLC announces a voluntary field action for the Blackrock NeuroPort Biopotential Signal Processing System because the Neural Signal Amplifier and the Patient Cable are incorrectly labeled as Type CF Applied Parts.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-2763-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.